NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,197,185 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$531,700 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $354,498 to $974,870.

Keywords {🔍}

cells, irx, gefitinib, cancer, nanog, cell, expression, pcgr, fig, article, resistance, properties, google, scholar, china, lung, western, cas, stemlike, ohd, treatment, stem, blotting, protein, nsclc, tumor, signaling, combination, tgfβ, cytotoxicity, results, group, analysis, nature, egfrtki, increased, inhibited, stemness, experiments, transfected, usa, sirna, growth, celllike, treated, significantly, levels, assay, nanjing, viability,

Topics {✒️}

nature portfolio beta-catenin-mediated epithelial-mesenchymal transition vdr/plc-gamma1/tgf-beta1/pathway serum‐free opti‐mem media research groups privacy policy tgf-β/smad signaling-induced irx4 tgf-β1/smad3 signaling pathway tgf-β/smad signaling pathway28 nature small-molecule multi-kinase inhibitor20 advertising erk1/2-mzf1 signaling pathway reprints tgf-β1/smad3 signaling japan activating stat3/cxcl1 axis 2d3 signaling-induced decreases egfr-tyrosine kinase inhibitors small-cell lung cancer egfr-tki resistant cells irx4-mediated cancer stem potentiates cell death social media poor egfr-tki sensitivity inhibit egfr-tki resistance irx4-expressing cell lines nanog-mediated stem cell state key laboratory regulating egfr-tki resistance cd44+cd133+ pc-9/gr cells increase egfr-tki resistance high tgf-β1 levels irx-family genes participate egfr-mutant nsclc cells9 contract number hh20190622lhy-lv03 ventricular-specific progenitor cell multi-directional differentiation potential pnanog-luc reporter activity irx4+mouse embryonic cells original author tgf-β1 induced permissions sirna/plasmid‐lipid complexes lung cancer progression tyrosine kinase inhibitors 20 ng/ml tgf-β1 delayed development cell death dis pre-clinical models support

Questions {❓}

• How IRX4 controls gefitinib cytotoxicity?
• How to regulate IRX4-mediated cancer stem-like properties and gefitinib resistance?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
         description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
         datePublished:2020-08-20T00:00:00Z
         dateModified:2020-08-20T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41419-020-02908-w
         keywords:
            Cancer
            Cancer therapy
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhirong Jia
               url:http://orcid.org/0000-0002-7381-5150
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yameng Zhang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aiwen Yan
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Meisa Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiushuang Han
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kaiwei Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Wang
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:the First Affiliated Hospital of Xinjiang Medical University
                     address:
                        name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chen Qiao
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:China Pharmaceutical University
                     address:
                        name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhenzhen Pan
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chuansheng Chen
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dong Hu
               affiliation:
                     name:Anhui University of Science and Technology
                     address:
                        name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Xuansheng Ding
               affiliation:
                     name:China Pharmaceutical University
                     address:
                        name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:China Pharmaceutical University
                     address:
                        name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:1,25-dihydroxyvitamin D3 signaling-induced decreases in IRX4 inhibits NANOG-mediated cancer stem-like properties and gefitinib resistance in NSCLC cells
      description:Recent studies have demonstrated that acquisition of cancer stem-like properties plays an essential role in promoting epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) resistance in non-small cell lung cancer (NSCLC); however, how to regulate cancer stem-like properties and EGFR-TKI resistance is largely unclear. In this study, we discovered that increased iroquois-class homeodomain protein 4 (IRX4) was related to gefitinib resistance in NSCLC cells. Knockdown of IRX4 inhibited cell proliferation, sphere formation, and the expression of CD133, ALDH1A1, NANOG, Sox2 and Notch1, and the transcriptional activity of NANOG promoter. IRX4 overexpression increased the protein level of NANOG and CD133 in PC-9 cells. Combination of knocking-down IRX4 with gefitinib increased cell apoptosis and decreased cell viability and the expression of p-EGFR and NANOG in PC-9/GR cells. IRX4 knockdown in a PC-9/GR xenograft tumor model inhibited tumor progression and the expression of NANOG and CD133 more effectively than single treatment alone. Knockdown of NANOG inhibited the expression of CD133 and restored gefitinib cytotoxicity, and NANOG overexpression-induced cancer stem-like properties and gefitinib resistance could be obviously reversed by knocking-down IRX4. Further, we found that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) reduced obviously the expression of IRX4 and NANOG by inhibiting the activation of TGF-β1/Smad3 signaling pathway; moreover, combination of 1,25(OH)2D3 and gefitinib decreased cell viability and proliferation or tumor progression and the expression of IRX4 and NANOG compared with single treatment alone both in PC-9/GR cells and in a PC-9/GR xenograft tumor model. These results reveal that inhibition of IRX4-mediated cancer stem-like properties by regulating 1,25(OH)2D3 signaling may increase gefitinib cytotoxicity. Combination therapy of gefitinib and 1,25(OH)2D3 by targeting IRX4 and NANOG, could provide a promising strategy to improve gefitinib cytotoxicity.
      datePublished:2020-08-20T00:00:00Z
      dateModified:2020-08-20T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41419-020-02908-w
      keywords:
         Cancer
         Cancer therapy
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41419-020-02908-w/MediaObjects/41419_2020_2908_Fig8_HTML.png
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhirong Jia
            url:http://orcid.org/0000-0002-7381-5150
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yameng Zhang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aiwen Yan
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Meisa Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiushuang Han
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kaiwei Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Wang
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:the First Affiliated Hospital of Xinjiang Medical University
                  address:
                     name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chen Qiao
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:China Pharmaceutical University
                  address:
                     name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhenzhen Pan
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chuansheng Chen
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dong Hu
            affiliation:
                  name:Anhui University of Science and Technology
                  address:
                     name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Xuansheng Ding
            affiliation:
                  name:China Pharmaceutical University
                  address:
                     name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:China Pharmaceutical University
                  address:
                     name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:11
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:the First Affiliated Hospital of Xinjiang Medical University
      address:
         name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:Anhui University of Science and Technology
      address:
         name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
      name:China Pharmaceutical University
      address:
         name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhirong Jia
      url:http://orcid.org/0000-0002-7381-5150
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Yameng Zhang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Aiwen Yan
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Meisa Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Qiushuang Han
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Kaiwei Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Jie Wang
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:the First Affiliated Hospital of Xinjiang Medical University
            address:
               name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
               type:PostalAddress
            type:Organization
      name:Chen Qiao
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:China Pharmaceutical University
            address:
               name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Zhenzhen Pan
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Chuansheng Chen
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Dong Hu
      affiliation:
            name:Anhui University of Science and Technology
            address:
               name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Xuansheng Ding
      affiliation:
            name:China Pharmaceutical University
            address:
               name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:China Pharmaceutical University
            address:
               name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education, Medical School, Anhui University of Science and Technology, Huainan, China
      name:School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
      name:Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(114)

• How much cash flow does https://orcid.org/0000-0002-7381-5150 have monthly?
• How much income is https://doi.org/10.1016%2FS0140-6736%2817%2933326-3 earning monthly?
• What's http://scholar.google.com/scholar_lookup?&title=Global%20surveillance%20of%20trends%20in%20cancer%20survival%202000-14%20%28CONCORD-3%29%3A%20analysis%20of%20individual%20records%20for%2037%20513%20025%20patients%20diagnosed%20with%20one%20of%2018%20cancers%20from%20322%20population-based%20registries%20in%2071%20countries&journal=Lancet&doi=10.1016%2FS0140-6736%2817%2933326-3&volume=391&pages=1023-1075&publication_year=2018&author=Allemani%2CC's gross income?
• How much profit is https://doi.org/10.1200%2FJCO.2012.45.3753 making per month?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Genotyping%20and%20genomic%20profiling%20of%20non-small-cell%20lung%20cancer%3A%20implications%20for%20current%20and%20future%20therapies&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.2012.45.3753&volume=31&pages=1039-1049&publication_year=2013&author=Li%2CT&author=Kung%2CHJ&author=Mack%2CPC&author=Gandara%2CDR
• What's the income of https://doi.org/10.6004%2Fjnccn.2018.0062?
• How much does http://scholar.google.com/scholar_lookup?&title=NCCN%20guidelines%20insights%3A%20non-small%20cell%20lung%20cancer%2C%20Version%205.2018&journal=J.%20Natl%20Compr.%20Canc%20Netw.&doi=10.6004%2Fjnccn.2018.0062&volume=16&pages=807-821&publication_year=2018&author=Ettinger%2CDS pull in?
• Earnings of https://doi.org/10.1038%2Fcddis.2014.447
• Revenue of http://scholar.google.com/scholar_lookup?&title=A%20novel%20antagonist%20to%20the%20inhibitors%20of%20apoptosis%20%28IAPs%29%20potentiates%20cell%20death%20in%20EGFR-overexpressing%20non-small-cell%20lung%20cancer%20cells&journal=Cell%20Death%20Dis.&doi=10.1038%2Fcddis.2014.447&volume=5&publication_year=2014&author=Lee%2CSH
• What's the financial intake of https://doi.org/10.2174%2F1574887114666181205155211?
• How much does http://scholar.google.com/scholar_lookup?&title=Advanced%20non-small%20cell%20lung%20cancer%20with%20activating%20epidermal%20growth%20factor%20receptor%20mutation%3A%20first%20line%20treatment%20and%20beyond&journal=Rev.%20Recent%20Clin.%20Trials&doi=10.2174%2F1574887114666181205155211&volume=14&pages=120-128&publication_year=2019&author=Rocco%2CD&author=Battiloro%2CC&author=Gravara%2CLD&author=Gridelli%2CC net monthly?
• How much does https://link.springer.com/doi/10.1007/s40264-018-0772-x earn?
• How much income is http://scholar.google.com/scholar_lookup?&title=Safety%20and%20tolerability%20of%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%20tyrosine%20kinase%20inhibitors%20in%20oncology&journal=Drug%20Saf.&doi=10.1007%2Fs40264-018-0772-x&volume=42&pages=181-198&publication_year=2019&author=Shah%2CRR&author=Shah%2CDR earning monthly?
• How much profit is https://doi.org/10.1016%2Fj.resinv.2018.09.001 making per month?
• How much does http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20molecularly%20targeted%20therapy%20in%20non-small-cell%20lung%20cancer&journal=Respir.%20Investig.&doi=10.1016%2Fj.resinv.2018.09.001&volume=57&pages=20-26&publication_year=2019&author=Asao%2CT&author=Takahashi%2CF&author=Takahashi%2CK bring in each month?
• How much does https://doi.org/10.1111%2Fcas.12749 bring in each month?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS?
• See how much https://doi.org/10.1038%2Fs41467-018-05626-2 makes per month
• How much profit does http://scholar.google.com/scholar_lookup?&title=Notch3-dependent%20beta-catenin%20signaling%20mediates%20EGFR%20TKI%20drug%20persistence%20in%20EGFR%20mutant%20NSCLC&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-018-05626-2&volume=9&publication_year=2018&author=Arasada%2CRR generate?
• What's https://doi.org/10.1111%2Fcrj.12976's gross income?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=CD146-mediated%20acquisition%20of%20stemness%20phenotype%20enhances%20tumour%20invasion%20and%20metastasis%20after%20EGFR-TKI%20resistance%20in%20lung%20cancer&journal=Clin.%20Respir.%20J.&doi=10.1111%2Fcrj.12976&volume=13&pages=23-33&publication_year=2019&author=Zhang%2CF?
• https://doi.org/10.1158%2F0008-5472.CAN-12-4136 income
• What's the income of http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&pages=3051-3061&publication_year=2013&author=Shien%2CK?
• https://doi.org/10.1016%2Fj.canlet.2018.07.020's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Genome-wide%20identification%20of%20transcription%20factors%20that%20are%20critical%20to%20non-small%20cell%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2018.07.020&volume=434&pages=132-143&publication_year=2018&author=Zhang%2CDL pull in monthly?
• https://link.springer.com/doi/10.1007/s00429-016-1326-6 income
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Expression%20patterns%20of%20Irx%20genes%20in%20the%20developing%20chick%20inner%20ear&journal=Brain%20Struct.%20Funct.&doi=10.1007%2Fs00429-016-1326-6&volume=222&pages=2071-2092&publication_year=2017&author=Cardena-Nunez%2CS?
• What's the financial outcome of https://doi.org/10.1038%2Fncomms1301?
• How much does http://scholar.google.com/scholar_lookup?&title=An%20evolutionarily%20conserved%20three-dimensional%20structure%20in%20the%20vertebrate%20Irx%20clusters%20facilitates%20enhancer%20sharing%20and%20coregulation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1301&volume=2&publication_year=2011&author=Tena%2CJJ make?
• Profit of https://doi.org/10.1002%2Fstem.2486
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Irx4%20marks%20a%20multipotent%2C%20ventricular-specific%20progenitor%20cell&journal=Stem%20Cells&doi=10.1002%2Fstem.2486&volume=34&pages=2875-2888&publication_year=2016&author=Nelson%2CDO?
• How much money does https://doi.org/10.1016%2Fj.mcn.2008.11.003 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Formation%20of%20posterior%20cranial%20placode%20derivatives%20requires%20the%20Iroquois%20transcription%20factor%20irx4a&journal=Mol.%20Cell%20Neurosci.&doi=10.1016%2Fj.mcn.2008.11.003&volume=40&pages=328-337&publication_year=2009&author=Feijoo%2CCG&author=Saldias%2CMP&author=Paz%2CJF&author=Gomez-Skarmeta%2CJL&author=Allende%2CML earn?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22213310
• How much does http://scholar.google.com/scholar_lookup?&title=Vitamin%20D%3A%20potential%20in%20the%20prevention%20and%20treatment%20of%20lung%20cancer&journal=Anticancer%20Res.&volume=32&pages=211-221&publication_year=2012&author=Norton%2CR&author=O%E2%80%99Connell%2CMA net monthly?
• Learn how profitable https://doi.org/10.1016%2Fj.jsbmb.2012.09.022 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=Differential%20response%20to%201alpha%2C25-dihydroxyvitamin%20D3%20%281alpha%2C25%28OH%292D3%29%20in%20non-small%20cell%20lung%20cancer%20cells%20with%20distinct%20oncogene%20mutations&journal=J.%20Steroid%20Biochem%20Mol.%20Biol.&doi=10.1016%2Fj.jsbmb.2012.09.022&volume=136&pages=264-270&publication_year=2013&author=Zhang%2CQ pull in monthly?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31002352
• http://scholar.google.com/scholar_lookup?&title=1alpha%2C25Dihydroxyvitamin%20D3%20restrains%20stem%20celllike%20properties%20of%20ovarian%20cancer%20cells%20by%20enhancing%20vitamin%20D%20receptor%20and%20suppressing%20CD44&journal=Oncol.%20Rep.&volume=41&pages=3393-3403&publication_year=2019&author=Ji%2CM&author=Liu%2CL&author=Hou%2CY&author=Li%2CB income
• Revenue of https://doi.org/10.1016%2Fj.stem.2018.11.017
• How much income is http://scholar.google.com/scholar_lookup?&title=Targeting%20cancer%20stemness%20in%20the%20clinic%3A%20from%20hype%20to%20hope&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.11.017&volume=24&pages=25-40&publication_year=2019&author=Saygin%2CC&author=Matei%2CD&author=Majeti%2CR&author=Reizes%2CO&author=Lathia%2CJD earning monthly?
• Discover the revenue of https://doi.org/10.1016%2Fj.canlet.2019.03.027
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Protective%20autophagy%20decreases%20osimertinib%20cytotoxicity%20through%20regulation%20of%20stem%20cell-like%20properties%20in%20lung%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2019.03.027&volume=452&pages=191-202&publication_year=2019&author=Li%2CL produce monthly?
• What's the monthly income of https://doi.org/10.1038%2Fs41388-018-0589-1?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20are%20dependent%20on%20purine%20synthetic%20metabolism%20mediated%20by%20the%20mitochondrial%20enzyme%20MTHFD2&journal=Oncogene&doi=10.1038%2Fs41388-018-0589-1&volume=38&pages=2464-2481&publication_year=2019&author=Nishimura%2CT?
• Revenue of https://doi.org/10.18632%2Foncotarget.3389
• What's the income of http://scholar.google.com/scholar_lookup?&title=IL-8%20confers%20resistance%20to%20EGFR%20inhibitors%20by%20inducing%20stem%20cell%20properties%20in%20lung%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3389&volume=6&pages=10415-10431&publication_year=2015&author=Liu%2CYN?
• How much does https://doi.org/10.1002%2Fstem.29 rake in every month?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Functional%20evidence%20that%20the%20self-renewal%20gene%20NANOG%20regulates%20human%20tumor%20development&journal=Stem%20Cells&doi=10.1002%2Fstem.29&volume=27&pages=993-1005&publication_year=2009&author=Jeter%2CCR
• What are the total earnings of https://doi.org/10.1158%2F0008-5472.CAN-10-3320?
• How much income is http://scholar.google.com/scholar_lookup?&title=HIF%20induces%20human%20embryonic%20stem%20cell%20markers%20in%20cancer%20cells&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-10-3320&volume=71&pages=4640-4652&publication_year=2011&author=Mathieu%2CJ earning monthly?
• How much revenue does https://doi.org/10.1016%2Fj.suronc.2013.08.001 produce monthly?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Nanog%2C%20a%20novel%20prognostic%20marker%20for%20lung%20cancer&journal=Surg.%20Oncol.&doi=10.1016%2Fj.suronc.2013.08.001&volume=22&pages=224-229&publication_year=2013&author=Du%2CY have monthly?
• How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-14-2437 bring in?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Activation%20of%20vitamin%20D%20receptor%20signaling%20downregulates%20the%20expression%20of%20nuclear%20FOXM1%20protein%20and%20suppresses%20pancreatic%20cancer%20cell%20stemness&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-14-2437&volume=21&pages=844-853&publication_year=2015&author=Li%2CZ?
• How much does https://doi.org/10.1111%2Fcas.14237 bring in each month?
• Get to know http://scholar.google.com/scholar_lookup?&title=Calcitriol%20inhibits%20migration%20and%20invasion%20of%20renal%20cell%20carcinoma%20cells%20by%20suppressing%20Smad2%2F3-%2C%20STAT3-%20and%20beta-catenin-mediated%20epithelial-mesenchymal%20transition&journal=Cancer%20Sci.&doi=10.1111%2Fcas.14237&volume=111&pages=59-71&publication_year=2020&author=Xu%2CS's earnings
• What's the revenue for https://doi.org/10.1016%2Fj.molimm.2017.09.006?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=1%2C25%28OH%292D3%20induces%20regulatory%20T%20cell%20differentiation%20by%20influencing%20the%20VDR%2FPLC-gamma1%2FTGF-beta1%2Fpathway&journal=Mol.%20Immunol.&doi=10.1016%2Fj.molimm.2017.09.006&volume=91&pages=156-164&publication_year=2017&author=Zhou%2CQ
• How much income is https://doi.org/10.1038%2Fs41556-018-0062-y earning monthly?
• http://scholar.google.com/scholar_lookup?&title=PSPC1%20mediates%20TGF-beta1%20autocrine%20signalling%20and%20Smad2%2F3%20target%20switching%20to%20promote%20EMT%2C%20stemness%20and%20metastasis&journal=Nat.%20Cell%20Biol.&doi=10.1038%2Fs41556-018-0062-y&volume=20&pages=479-491&publication_year=2018&author=Yeh%2CHW's total income per month
• Get to know what's the income of https://doi.org/10.1111%2Ffebs.14162
• How much revenue does http://scholar.google.com/scholar_lookup?&title=TGF-beta1-induced%20CK17%20enhances%20cancer%20stem%20cell-like%20properties%20rather%20than%20EMT%20in%20promoting%20cervical%20cancer%20metastasis%20via%20the%20ERK1%2F2-MZF1%20signaling%20pathway&journal=FEBS%20J.&doi=10.1111%2Ffebs.14162&volume=284&pages=3000-3017&publication_year=2017&author=Wu%2CL generate?
• Get to know what's the income of https://doi.org/10.1016%2Fj.biopha.2015.10.018
• Get to know http://scholar.google.com/scholar_lookup?&title=TGF-beta1%20induces%20erlotinib%20resistance%20in%20non-small%20cell%20lung%20cancer%20by%20down-regulating%20PTEN&journal=Biomed.%20Pharmacother.&doi=10.1016%2Fj.biopha.2015.10.018&volume=77&pages=1-6&publication_year=2016&author=Shen%2CH's earnings
• What's the revenue for https://doi.org/10.1158%2F1535-7163.MCT-13-0448?
• How much money does http://scholar.google.com/scholar_lookup?&title=MiR-134%2F487b%2F655%20cluster%20regulates%20TGF-beta-induced%20epithelial-mesenchymal%20transition%20and%20drug%20resistance%20to%20gefitinib%20by%20targeting%20MAGI2%20in%20lung%20adenocarcinoma%20cells&journal=Mol.%20Cancer%20Ther.&doi=10.1158%2F1535-7163.MCT-13-0448&volume=13&pages=444-453&publication_year=2014&author=Kitamura%2CK generate?
• How much does https://doi.org/10.1038%2Fncomms1880 pull in?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Loss-of-function%20of%20inositol%20polyphosphate-4-phosphatase%20reversibly%20increases%20the%20severity%20of%20allergic%20airway%20inflammation&journal=Nat.%20Commun.&doi=10.1038%2Fncomms1880&volume=3&publication_year=2012&author=Aich%2CJ&author=Mabalirajan%2CU&author=Ahmad%2CT&author=Agrawal%2CA&author=Ghosh%2CB
• What's the financial gain of https://doi.org/10.1073%2Fpnas.1009472107?
• How much does http://scholar.google.com/scholar_lookup?&title=TGF-beta%20IL-6%20axis%20mediates%20selective%20and%20adaptive%20mechanisms%20of%20resistance%20to%20molecular%20targeted%20therapy%20in%20lung%20cancer&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1009472107&volume=107&pages=15535-15540&publication_year=2010&author=Yao%2CZ make?
• What's the total monthly financial gain of https://link.springer.com/doi/10.1186/s13046-019-1120-4?
• What's http://scholar.google.com/scholar_lookup?&title=Co-administration%20of%2020%28S%29-protopanaxatriol%20%28g-PPT%29%20and%20EGFR-TKI%20overcomes%20EGFR-TKI%20resistance%20by%20decreasing%20SCD1%20induced%20lipid%20accumulation%20in%20non-small%20cell%20lung%20cancer&journal=J.%20Exp.%20Clin.%20Cancer%20Res&doi=10.1186%2Fs13046-019-1120-4&volume=38&publication_year=2019&author=Huang%2CQ's gross income?
• Discover the revenue of https://link.springer.com/doi/10.1186/s13046-018-0894-0
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=FOXC1%20induces%20cancer%20stem%20cell-like%20properties%20through%20upregulation%20of%20beta-catenin%20in%20NSCLC&journal=J.%20Exp.%20Clin.%20Cancer%20Res.&doi=10.1186%2Fs13046-018-0894-0&volume=37&publication_year=2018&author=Cao%2CS?
• Get to know what's the income of https://doi.org/10.1158%2F1078-0432.CCR-13-2613
• How much does http://scholar.google.com/scholar_lookup?&title=Metformin%20sensitizes%20EGFR-TKI-resistant%20human%20lung%20cancer%20cells%20in%20vitro%20and%20in%20vivo%20through%20inhibition%20of%20IL-6%20signaling%20and%20EMT%20reversal&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-13-2613&volume=20&pages=2714-2726&publication_year=2014&author=Li%2CL gross monthly?
• How much money does https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=references make?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhirong%20Jia?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhirong%20Jia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yameng%20Zhang generate monthly?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yameng%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aiwen%20Yan
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aiwen%20Yan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Meisa%20Wang
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Meisa%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qiushuang%20Han's financial summary
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qiushuang%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaiwei%20Wang
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaiwei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Wang?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chen%20Qiao net monthly?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chen%20Qiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhenzhen%20Pan?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhenzhen%20Pan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chuansheng%20Chen make?
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chuansheng%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dong%20Hu's earnings
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xuansheng%20Ding?
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xuansheng%20Ding%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the profit of http://creativecommons.org/licenses/by/4.0/?
• What's the total monthly financial gain of https://s100.copyright.com/AppDispatchServlet?title=1%2C25-dihydroxyvitamin%20D3%20signaling-induced%20decreases%20in%20IRX4%20inhibits%20NANOG-mediated%20cancer%20stem-like%20properties%20and%20gefitinib%20resistance%20in%20NSCLC%20cells&author=Zhirong%20Jia%20et%20al&contentID=10.1038%2Fs41419-020-02908-w©right=The%20Author%28s%29&publication=2041-4889&publicationDate=2020-08-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY?
• Learn how profitable https://crossmark.crossref.org/dialog/?doi=10.1038/s41419-020-02908-w is on a monthly basis
• Check the income stats for https://citation-needed.springer.com/v2/references/10.1038/s41419-020-02908-w?format=refman&flavour=citation
• https://doi.org/10.1007/s10555-024-10171-0's revenue stream
• How much money does https://doi.org/10.1186/s12943-023-01877-w make?
• Income figures for https://doi.org/10.1007/s12032-023-02210-7
• How much revenue does https://doi.org/10.1038/s41420-022-00918-5 generate?
• What's the financial outcome of https://www.protocols.io/?
• What's the total monthly financial gain of https://www.natureindex.com/?
• How much revenue does http://www.naturechina.com bring in?
• What's the monthly money flow for https://www.natureasia.com/ja-jp?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref